HEPATIC ENCEPHALOPATHY AND COMA AND END STAGE RENAL DSE HEPATIC ENCEPHALOPATHY AND COMA  Hepatic encephalopathy, is a lifethreatening complication of liver disease, occurs…

1. • 65 year old NH resident • Assisted with ADL, limited mobility • Decreased oral intake • Staring straight ahead for long periods x 3 days • Muscular rigidity,…

1. Dr: Wael H.Mansy, MDDr: Wael H.Mansy, MD Assistant ProfessorAssistant Professor College of PharmacyCollege of Pharmacy King Saud UniversityKing Saud University Disease…

Slide 1The Challenges of Pharmacovigilance I. Ralph Edwards Courage is the human virtue that counts mostcourage to act on limited knowledge and insufficient evidence. That's…

Slide 1Bronchoprovocation test Presented by: Ashraf Abbas ELMaraghy,MD. Lecturer of Chest Diseases, Ain Shams University. Slide 2 At the end of this lecture you would be…

Slide 1Developments in End of Life Care John Sheridan End of Life Care Clinical Educator Slide 2 Tools available in the trust AMBER care bundle Last Days of Life Care Plan…

Slide 1Catheter Ablation in the Treatment of Atrial Fibrillation Slide 2 First described in 1903 by Hering Most common sustained arrhythmia Atrial Fibrillation Slide 3 Atrial…

1.D102. D.10.1 Describe the effects of lysergic aciddiethylamide (LSD), mescaline, psilocybin andtetrahydrocannabinol• Lysergic Acid Diethylamide (LSD)• - does not occur…

1. HOST MODULATION AND AGENTS 2. CONTENTS • • •INTRODUCTION DEFINITIONS PATHOGENESIS OF PERIODONTITIS AND THE HOST RESPONSE HOST MODULATION THERAPY (HMT)• – –…

1. The Challenges of Pharmacovigilance Presented by:- Dr. ROCHAK SONI ICRI (DELHI). 2. Content: Pharmacovigilance Need for Pharmacovigilance Challenges of Pharmacovigilance…